Our sectors

We treat all personal data in accordance with our privacy policy.

Textured Breast Implant Claims

In December 2018, Allergan textured breast implants were removed from the market in Europe due to them being linked to a rare form of cancer called Breast Implant Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL).

Reported symptoms tend to describe a late onset of painful swollen breasts with a fluid collection usually between three and 14 years after implantation. Although investigations into the pathology of BIA-ALCL continue, positive outcomes have been reported and in most cases patients have achieved complete remission.

Leigh Day is currently investigating claims on behalf of women who have had a diagnosis of BIA-ALCL or are being investigated for BIA-ALCL. If you would like to speak to a member of our team regarding a potential BIA-ALCL claim, please email us.

If you have not had a diagnosis of BIA-ALCL but are concerned about developing this condition, and would like to be added to our mailing list so that we can keep you up to date on what we are doing at Leigh Day in regards to BIA-ALCL, register your interest and we can inform you if we are able to pursue legal action for you in the future.  
Register your interest

Julie's story

Julie Harris had the Allergan textured breast implants in 2011.

In 2018, she was diagnosed with Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)

Watch her story below.

Share this page: Print this page